Abstract Background and Methods. Fifty‐one patients with small cell lung cancer (SCLC)
were treated with alternating urokinase (UK)‐cyclophosphamide‐doxorubicin (Adriamycin …

Twenty-five patients were treated with intensive chemotherapy for small cell carcinoma of
the lung. Twelve patients received concurrent urokinase and combination chemotherapy in …

Aim: The aim of this study was to evaluate the activity of the combination of carboplatin and
vinorelbine in patients with poor prognosis small cell lung cancer (SCLC). Patients with …

PURPOSE To determine whether the addition of ifosfamide to cisplatin plus etoposide
improves the response rate, time to disease progression, or overall survival in previously …

One hundred and eleven previously untreated patients with extensive small cell lung cancer
were included in a prospective randomized study with the aim to assess the efficacy and …

Sixty‐six patients were entered into a prospective, randomized clinical trial evaluating the
use of alternating noncross‐resistant chemotherapy in patients with extensive small cell …

Purpose A prospective randomized trial in small-cell lung cancer (SCLC) was performed to
determine if intensification of the platinum dose by giving cisplatin and carboplatin in …

Fifty-two previously untreated patients with small-cell lung carcinoma (SCLC) were treated
with a combination of carboplatin 300 mg/m2 intravenously (IV) on day 1 and etoposide 100 …

Lung cancer is the most common cause of cancer death in men and women in North
America. A recent analysis of the Surveillance, Epidemiology and End Results database …

Forty-four patients with small cell lung cancer were treated with an intensive chemotherapy
induction program consisting of combination cyclophosphamide, Adriamycin, and vincristine …